ValiMed(TM) MVS and ID2 Meth Scanner(TM) by CDEX Awarded GSA Contract Status

CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) and All Business Machines, Inc. ("ABMI") (www.abmicorp.com) announce that the ValiMed(TM) MVS (Medication Validation System) and ID2 Meth Scanner(TM) product lines by CDEX have been placed on the ABMI GSA Contract Schedule. ValiMed MVS puts a technological safety net between the patient and errors made in the compounding of high risk medications and guards against narcotic diversion. Both are now available to the Government markets through the ABMI GSA Schedule.

"Medical studies demonstrate that human errors in compounding of high-risk medications occur all too frequently and result in permanent harm to patients," said Karl Ross, President of ABMI. "ValiMed MVS provides an answer that is saving lives today. We are pleased to partner with CDEX in bringing this lifesaving product line, as well as the ID2 Meth Scanner, to the Government market on our GSA Contract Schedule. There has been a great deal of interest for both products and we now have a contract vehicle to make it happen."

"We are very pleased to be on the GSA Schedule and look forward to working more closely with ABMI in Government markets," said Malcolm Philips, CDEX CEO. "Interest in our two product lines continues to be strong. Being placed on the GSA Schedule is happening at the right time with a thawing in the economic markets. We see 2010 shaping up to be a very good year for CDEX sales."

About CDEX

CDEX develops, manufactures and globally distributes products to the healthcare and security markets. The ValiMed(TM) MVS product line provides life-saving validation of high-risk medications and returned narcotics. The ID2(TM) product line detects trace amounts of illegal drugs, such as methamphetamine. CDEX expects to advance its patented technologies to serve additional markets. To meet its plans, CDEX must strengthen its financial position as stated periodically in its SEC filings. For more information, contact Malcolm Philips at mphilips@cdex-inc.com.

About ABMI

ABMI Corporation is a Service-Disabled Veteran-Owned Small Business and an SBA certified HUB-Zone Corporation that has partnered with Fortune 500 Companies such as Grainger, Agilent Technologies, and Goodyear to manage procurement contract processes related to Public Policy Goal Attainment acquisitions. ABMI has a proven record of providing the highest quality products, with proven customer satisfaction, translating into a very strong reputation among Veteran Administration Hospitals and Federal Agencies. For more information see www.abmicorp.com.

Non-historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as "expects," "plans," "may," "believes," "should," "intends," and similar words. These statements pose risks that cannot be accurately predicted. Consequently, results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the protection of intellectual property and proprietary information, and other risks detailed periodically in filings with the SEC. There is no obligation to update any forward-looking statements.

Contact:
Malcolm Philips
Email Contact

SOURCE: CDEX Inc.

http://www2.marketwire.com/mw/emailprcntct?id=FDD9FBE1BB24EBD3

Related terms: acquisition, ceo, contract, email, federal, government, manufacturer, market, medical, president, products, property, public policy, sales, scanner, schedule, sec, securities, security, small business, technology